Tom
Lenz
Director, Pharmacy Distance Pathway; Associate Professor of Pharmacy Practice
Pharm.D., M.A.
Pharmacy Practice
Email:
tlenz@creighton.edu
402 280-3144
Biography:
Cardiovascular Research Fellow Creighton University, School of Medicine Omaha, Nebraska. 2001;
Doctor of Pharmacy Creighton University, School of Pharmacy and Allied Health Professions Omaha, Nebraska. 1999;
Master of Arts University of Nebraska - Omaha (Exercise Science) Omaha, Nebraska. 1995;
Bachelor of Arts Creighton University, College of Arts and Sciences (Exercise Science) Omaha, Nebraska. 1992
Publications:
Selected Publication List:
Books:
Lenz TL. Lifestyle Modifications in Pharmacotherapy. Lippincott, Williams, and Wilkins. Baltimore. 2008.
Peer Reviewed Journal Manuscripts:
Lenz TL. Development of an Elective Course on Lifestyle Modifications in Pharmacotherapy. Am J Pharm Educ. Accepted and in Press.
Lenz TL, Monaghan MS, Hayes MM, Hetterman EA. Health promotion and wellness courses taught in U.S. pharmacy programs. Preventing Chronic Disease. Accepted and in Press.
Lenz TL, Monaghan MS, Eckler J, Hayes M. An interprofessional medication risk assessment program. J Interprof Care. 2006;20(5):558-560.
Faulkner MA, Lenz TL, Stading JA. Cost-effectiveness of smoking cessation and implications for COPD. International Journal of COPD. 2006;1(3):279-287.
Lenz TL, Faulkner MA, Monaghan MS. Using two-way interactive video (TWIV) conferencing to offer disease state management continuing education to rural pharmacists. Journal of Pharmacy Teaching. 2006;13(1):29-36.
Lenz TL, Monaghan MS, Wilson AF, Tilleman JA, Jones RM, Hayes MH. Using performance-based assessments to evaluate parity between a campus and distance education pathway. Am J Pharm Educ. 2006;70(4):article 90.
Lenz TL. Instructor workload of a campus-based versus a web-based pharmacy course. Journal of Pharmacy Teaching. 2005;12(2):97-106.
Lenz TL, Stading JA. Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health care professionals. J Am Pharm Assoc. 2005;45:709-713.
Lenz TL, Jones RM, Monaghan MS. Faculty workload comparison between a campus-based and internet-based patient assessment course. Am J Pharm Educ. 2005;69(4):article 67.
Lenz TL. Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemia in adults. J Am Pharm Assoc. 2005;45:492-502.
Monaghan MS, Jones RM, Faculty Case Writing Teams. Designing an assessment for an abilities-based curriculum. Am J Pharm Educ. 2005;69(2):article 19.
Faulkner MA, Ryan-Haddad AM, Lenz TL, Degner K. Osteoporosis in long-term care residents with multiple sclerosis. Consult Pharm 2005;20:128-136.
Hunter CB, Ndemo F, Lenz TL, Maciejewski S, Hilleman DE. Nesiritide for heart failure: Impact on cost and complications. Expert Rev Pharmacoeconomics Outcomes Res 2005;5:15-21.
Lenz TL, Hilleman DE. Nesiritide usage in decompensated heart failure: cost effectiveness and clinical effectiveness. Heart Drug 2005;5(2):81-88.
Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: The Reducton in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004;148:641-648.
Lenz TL, Foral PA, Malesker MA, Hunter CB, Hilleman DE. Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure. Pharmacotherapy 2004; 24(9):1137-1146.
Lenz TL, Faulkner MA, Ryan-Haddad A. Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia. Advances in Pharmacy. 2004;2(2):136-145.
Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med 2004;34(5):293-306.
Lenz TL, Hamilton WR. Supplemental products used for weight loss. J Am Pharm Assoc. 2004;44:59-68.
Lenz TL, Wilson AF. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke. Clin Pharmacokinet 2003; 42(10):909-920.
Faulkner MA, Bertoni JM, Lenz TL. Gabapentin for the treatment of tremor. Ann Pharmacother 2003;37:282-286.
Packard KA, Backes JM, Lenz TL, Wurdeman RL, Destache CJ, Hilleman DE. Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease. Pharmacotherapy 2002;22(12):1527-1532.
Wurdeman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery. Chest. 2002;121:1203-1210.
Lenz TL, Hilleman DE. The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease. P&T. 2001;26:100-106.
Lenz TL, Wurdeman RL, Hilleman DE. Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine. Pharmacotherapy 2001;21(8):898-903.
Hilleman DE, Wurdeman RL, Lenz TL. Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease. Pharmacotherapy 2001;21(4):410-415.
Instructor in:
PHA 308, Lifestyle Modifications in Pharmacotherapy;
PHA 330, Exercise and Sports Pharmacy;
PHA 450, Pharmacotherapeutics;
Research Interests:
Lifestyle modifications for patients with chronic diseases; Disease prevention; Cardiology
office:
Creighton University
Department of Pharmacy Practice
2500 California Plz
Omaha, NE 68178
office_hrs:
Fax:
402 280-3320
Pager:
|